Pyxis Oncology Inc (PYXS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $188.98M
Last updated: Nov 17, 2026 at 4:26 PM ET
Pyxis Oncology Inc (PYXS) Stock Chart
Pyxis Oncology (PYXS) has a latest price of $1.44 on Nov 17, 2026, 74.1% below its 52-week high of $5.55. Its price fell 67.0% over the past 12 months. The month-end price fell 86.4% over the 5 years through Oct 2026, a compound annual decline of 32.9%.
Price Chart
From Oct 2021 to Oct 2026, its highest month-end close was $13.34 in Oct 2021 and its lowest $0.98 in Mar 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PYXS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PYXS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 57.3%, and over 6 months it fell 24.6%. The month-end price rose 8.4% over the 3 years through Oct 2026, a compound annual rate of 2.7%.
| Period | Change |
|---|---|
| 1 month | -18.2% |
| 3 months | -57.3% |
| 6 months | -24.6% |
| 12 months | -67.0% |
| 12 months, with dividends | -67.0% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +8.4% | +2.7% |
| 5 years | -86.4% | -32.9% |
Price by Year
Its best calendar year was 2023, when the price rose 34.3%, and its weakest was 2022, when it fell 87.8%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.81 | +57.4% |
| 2025 | $1.15 | -26.3% |
| 2024 | $1.56 | -13.3% |
| 2023 | $1.80 | +34.3% |
| 2022 | $1.34 | -87.8% |
Trading Range
The price is 35.3% below its 50-day average of $2.23 and 33.2% below its 200-day average of $2.16.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.44 | |
| 52-week high | $5.55 | -74.1% |
| 52-week low | $1.03 | +39.8% |
| 50-day average | $2.23 | -35.3% |
| 200-day average | $2.16 | -33.2% |
Price Risk
Over 3 years, its largest fall from a peak was 86.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.21 |
| Largest fall, 1 year | -80.1% |
| Largest fall, 3 years | -86.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PYXS
What is PYXS's 1-year price change?
Pyxis Oncology's price fell 67.0% over the past 12 months. With dividends included, the 12-month total return was -67.0%.
What is PYXS's 5-year price change?
Pyxis Oncology's month-end price fell 86.4% over the 5 years through Oct 2026, a compound annual decline of 32.9%. These figures leave out dividends.
What is PYXS's 52-week high and low?
Pyxis Oncology's 52-week high is $5.55 and its 52-week low is $1.03. Its latest price of $1.44 on Nov 17, 2026 is 74.1% below the high.
What is PYXS's beta?
Pyxis Oncology's 1-year beta against the S&P 500 is 1.21, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 80.1%.
Is the PYXS chart free?
Yes. Advanced Charting for PYXS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PYXS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors